Inhibition of hyaluronan export from human fibroblasts by inhibitors of multidrug resistance transporters.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 15345330)

Published in Biochem Pharmacol on October 01, 2004

Authors

Peter Prehm1, Udo Schumacher

Author Affiliations

1: Muenster University Hospital, Institute of Physiological Chemistry and Pathobiochemistry, Waldeyerstrasse 15, D-48149 Münster, Germany. prehm@uni-muenster.de

Articles citing this

Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid. Gastroenterology (2009) 1.89

Verapamil protects against cartilage degradation in osteoarthritis by inhibiting Wnt/β-catenin signaling. PLoS One (2014) 1.59

Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol (2008) 1.52

Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. Drug Resist Updat (2008) 1.49

ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res (2005) 1.37

Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides. Cancer Res (2009) 1.06

The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. J Biol Chem (2010) 1.04

Hyaluronan regulates cell behavior: a potential niche matrix for stem cells. Biochem Res Int (2012) 0.94

Annexin2 coating the surface of enlargeosomes is needed for their regulated exocytosis. EMBO J (2006) 0.94

Hyaluronic acid is radioprotective in the intestine through a TLR4 and COX-2-mediated mechanism. Am J Physiol Gastrointest Liver Physiol (2011) 0.91

Biosynthesis of hyaluronan: direction of chain elongation. Biochem J (2006) 0.88

Hyaluronan synthase mediates dye translocation across liposomal membranes. BMC Biochem (2012) 0.84

Hyaluronic acid regulates normal intestinal and colonic growth in mice. Am J Physiol Gastrointest Liver Physiol (2012) 0.84

Hyaluronan export through plasma membranes depends on concurrent K+ efflux by K(ir) channels. PLoS One (2012) 0.84

Inhibition of hyaluronan export reduces collagen degradation in interleukin-1 treated cartilage. Arthritis Res Ther (2008) 0.83

Hyaluronan Synthase: The Mechanism of Initiation at the Reducing End and a Pendulum Model for Polysaccharide Translocation to the Cell Exterior. Int J Cell Biol (2015) 0.82

Hyaluronan synthase polymerizing activity and control of product size are discrete enzyme functions that can be uncoupled by mutagenesis of conserved cysteines. Glycobiology (2012) 0.81

Positive side effects of Ca antagonists for osteoarthritic joints-results of an in vivo pilot study. J Orthop Surg Res (2015) 0.78

Evidence for protein-mediated fatty acid efflux by adipocytes. Acta Physiol (Oxf) (2011) 0.75

Articles by these authors

(truncated to the top 100)

Myeloperoxidase attracts neutrophils by physical forces. Blood (2010) 1.84

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy. Clin Cancer Res (2011) 1.75

Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance. J Clin Oncol (2002) 1.75

CEACAM1+ myeloid cells control angiogenesis in inflammation. Blood (2009) 1.57

Tetrastarch sustains pulmonary microvascular perfusion and gas exchange during systemic inflammation. Crit Care Med (2012) 1.40

Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer (2002) 1.38

Cartilage destruction in granulomatosis with polyangiitis (Wegener's granulomatosis) is mediated by human fibroblasts after transplantation into immunodeficient mice. Am J Pathol (2012) 1.29

PET imaging of CXCR4 receptors in cancer by a new optimized ligand. ChemMedChem (2011) 1.28

Brachyury expression predicts poor prognosis at early stages of colorectal cancer. Eur J Cancer (2011) 1.27

CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J Clin Oncol (2002) 1.21

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions. Mod Pathol (2013) 1.19

Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells. Mol Cancer (2012) 1.14

PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. J Nucl Med (2011) 1.13

Parthenogenetic stem cells for tissue-engineered heart repair. J Clin Invest (2013) 1.11

Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma. Int J Cancer (2013) 1.09

Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice. PLoS Pathog (2013) 1.08

Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer. J Biol Chem (2013) 1.07

Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer. J Cancer Res Clin Oncol (2011) 1.07

Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer. J Nucl Med (2008) 1.01

Hyaluronan export by the ABC transporter MRP5 and its modulation by intracellular cGMP. J Biol Chem (2007) 1.01

Expression and prognostic value of L1-CAM in breast cancer. Oncol Rep (2009) 1.00

Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer. Cancer (2010) 0.99

Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J Clin Invest (2006) 0.99

Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4. J Med Chem (2011) 0.98

Inhalation with fucose and galactose for treatment of Pseudomonas aeruginosa in cystic fibrosis patients. Int J Med Sci (2008) 0.98

Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression. Clin Cancer Res (2012) 0.97

Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. BMC Cancer (2010) 0.97

High-throughput identification of reference genes for research and clinical RT-qPCR analysis of breast cancer samples. J Clin Bioinforma (2013) 0.96

Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds. Mol Cancer (2013) 0.96

Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro. Toxicology (2005) 0.94

A simple and widely applicable method to 59Fe-radiolabel monodisperse superparamagnetic iron oxide nanoparticles for in vivo quantification studies. ACS Nano (2012) 0.93

Curcumin induces apoptosis in human neuroblastoma cells via inhibition of NFkappaB. Anticancer Res (2008) 0.92

Pseudomonas aeruginosa lectins I and II and their interaction with human airway cilia. J Laryngol Otol (2005) 0.92

Inhibition of HERG1 K+ channel protein expression decreases cell proliferation of human small cell lung cancer cells. Pflugers Arch (2011) 0.92

Low-grade and high-grade mammary carcinomas in WAP-T transgenic mice are independent entities distinguished by Met expression. Int J Cancer (2012) 0.91

Inositol 1,4,5-trisphosphate 3-kinase-A is a new cell motility-promoting protein that increases the metastatic potential of tumor cells by two functional activities. J Biol Chem (2009) 0.90

A dynamic model for tumour growth and metastasis formation. J Clin Bioinforma (2012) 0.90

The influence of dietary lectins on the cell proliferation of human breast cancer cell lines in vitro. Anticancer Res (2003) 0.89

The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma. J Pathol (2004) 0.89

Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro. Anticancer Drugs (2006) 0.89

The cytotoxic effect of mistletoe lectins I, II and III on sensitive and multidrug resistant human colon cancer cell lines in vitro. Toxicology (2002) 0.88

Lectin histochemistry of resected adenocarcinoma of the lung: helix pomatia agglutinin binding is an independent prognostic factor. Am J Pathol (2002) 0.88

High interstitial fluid pressure is associated with low tumour penetration of diagnostic monoclonal antibodies applied for molecular imaging purposes. PLoS One (2012) 0.88

Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro. Toxicology (2005) 0.88

Tailor-made quantum dot and iron oxide based contrast agents for in vitro and in vivo tumor imaging. ACS Nano (2012) 0.87

Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp--/rag2-- mice. Gut (2012) 0.87

Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastases. Anticancer Res (2009) 0.87

Neuronal differentiation by indomethacin and IBMX inhibits proliferation of small cell lung cancer cells in vitro. Lung Cancer (2011) 0.87

The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells. Eur J Cancer (2010) 0.86

The interaction between CD44 on tumour cells and hyaluronan under physiologic flow conditions: implications for metastasis formation. Histochem Cell Biol (2012) 0.86

Redifferentiation of chondrocytes and cartilage formation under intermittent hydrostatic pressure. Biotechnol Lett (2006) 0.86

Adhesion of small cell lung cancer cells to E- and P-selectin under physiological flow conditions: implications for metastasis formation. Histochem Cell Biol (2011) 0.86

Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells. Tumour Biol (2010) 0.85

Prognostic relevance of glycosylation-associated genes in breast cancer. Breast Cancer Res Treat (2014) 0.85

Selectin-deficiency reduces the number of spontaneous metastases in a xenograft model of human breast cancer. Cancer Lett (2012) 0.85

Cystic fibrosis transmembrane conductance regulator can export hyaluronan. Pathobiology (2010) 0.85

Influence of L1-CAM expression of breast cancer cells on adhesion to endothelial cells. J Cancer Res Clin Oncol (2012) 0.85

Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes. PLoS One (2011) 0.84

Endothelin-1 inhibits mucin secretion from ovine airway epithelial goblet cells. Am J Respir Cell Mol Biol (2004) 0.84

Hyaluronan export through plasma membranes depends on concurrent K+ efflux by K(ir) channels. PLoS One (2012) 0.84

HPA binding and metastasis formation of human breast cancer cell lines transplanted into severe combined immunodeficient (scid) mice. Cancer Lett (2005) 0.83

Increased numbers of spontaneous SCLC metastasis in absence of NK cells after subcutaneous inoculation of different SCLC cell lines into pfp/rag2 double knock out mice. Cancer Lett (2009) 0.83

Expression of the neural cell adhesion molecule and polysialic acid in human neuroblastoma cell lines. Int J Oncol (2011) 0.83

Functional role of inositol-1,4,5-trisphosphate-3-kinase-A for motility of malignant transformed cells. Int J Cancer (2011) 0.83

Proteome analysis of metastatic colorectal cancer cells recognized by the lectin Helix pomatia agglutinin (HPA). Proteomics (2007) 0.83

Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice. Int J Cancer (2014) 0.83

Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases. Cancer Lett (2006) 0.83

Tumorigenic WAP-T mouse mammary carcinoma cells: a model for a self-reproducing homeostatic cancer cell system. PLoS One (2010) 0.83

[18F]FDG and [18F]FLT PET-CT and MR imaging of human neuroblastomas in a SCID mouse xenograft model. Anticancer Res (2008) 0.83

Trastuzumab has anti-metastatic and anti-angiogenic activity in a spontaneous metastasis xenograft model of esophageal adenocarcinoma. Cancer Lett (2011) 0.82

Visualisation of neuroblastoma growth in a Scid mouse model using [18F]FDG and [18F]FLT-PET. Anticancer Res (2006) 0.82

Lectin histochemistry of metastasizing and non-metastasizing breast and colon cancer cells. Anticancer Res (2011) 0.82

Effects of bortezomib on human neuroblastoma cells in vitro and in a metastatic xenograft model. Anticancer Res (2009) 0.82

Lectin histochemistry of metastatic adenocarcinomas of the lung. Lung Cancer (2007) 0.82

Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients. Breast Cancer Res Treat (2015) 0.82

Coxsackie adenovirus receptor expression in carcinomas of the head and neck. Anticancer Res (2012) 0.81

XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model? PLoS One (2012) 0.81

Inhibition of hyaluronan export attenuates cell migration and metastasis of human melanoma. J Cell Biochem (2008) 0.81

Use of a microsecond Er:YAG laser in laryngeal surgery reduces collateral thermal injury in comparison to superpulsed CO2 laser. Eur Arch Otorhinolaryngol (2013) 0.81

Melanoma never says die. Exp Dermatol (2014) 0.81

Hyaluronate and its receptors in bone marrow. Acta Histochem (2006) 0.80

Are metastases from metastases clinical relevant? Computer modelling of cancer spread in a case of hepatocellular carcinoma. PLoS One (2012) 0.80

Expression of hyaluronate and hyaluronate synthase in human primary tumours and their metastases in scid mice. Cancer Lett (2002) 0.80

Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients. J Cancer Res Clin Oncol (2013) 0.80

The proteasome inhibitor bortezomib augments anti-proliferative effects of mistletoe lectin-I and the PPAR-gamma agonist rosiglitazone in human melanoma cells. Anticancer Res (2007) 0.79

Nilotinib and imatinib are comparably effective in reducing growth of human eosinophil leukemia cells in a newly established xenograft model. PLoS One (2012) 0.79

Ulex europeus agglutinin-I binding as a potential prognostic marker in ovarian cancer. Anticancer Res (2007) 0.79

Expression of DIAPH1 is up-regulated in colorectal cancer and its down-regulation strongly reduces the metastatic capacity of colon carcinoma cells. Int J Cancer (2013) 0.79

Expression of CD44 is associated with a metastatic pattern of human neuroblastoma cells in a SCID mouse xenograft model. Tumour Biol (2008) 0.79

Lectin histochemistry of the lymphoid organs of the chicken. Anat Embryol (Berl) (2003) 0.79

Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp. Acta Histochem (2009) 0.79

Depolarization of the membrane potential by hyaluronan. J Cell Biochem (2010) 0.79

Comparison of the direct effects of human adipose- and bone-marrow-derived stem cells on postischemic cardiomyoblasts in an in vitro simulated ischemia-reperfusion model. Stem Cells Int (2013) 0.78

E- and p-selectins are essential for repopulation of chronic myelogenous and chronic eosinophilic leukemias in a scid mouse xenograft model. PLoS One (2013) 0.78

Extracellular matrix alterations, accelerated leukocyte infiltration and enhanced axonal sprouting after spinal cord hemisection in tenascin-C-deficient mice. Acta Histochem (2013) 0.78

Picosecond infrared laser (PIRL): an ideal phonomicrosurgical laser? Eur Arch Otorhinolaryngol (2013) 0.78

The effect of the PPAR-gamma agonist rosiglitazone on neuroblastoma SK-N-SH cells in a metastatic xenograft mouse model. Oncol Res (2010) 0.78

Biological and molecular characterization of a new human ampullary cancer cell line. Anticancer Res (2003) 0.78

Neurogenic transdifferentiation of human adipose-derived stem cells? A critical protocol reevaluation with special emphasis on cell proliferation and cell cycle alterations. Histochem Cell Biol (2010) 0.78

Computer simulation of the metastatic progression. Methods Mol Biol (2014) 0.78